




KidneyRight Ventricular Function, Peripheral Edema,
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Technology, Boston, Massachusetts, USAIntroduction: The cardiorenal syndrome generally focuses on left ventricular function, and the importance
of the right ventricle as a determinant of renal function is described less frequently. In a cohort of critically
ill patients with echocardiographic measurements obtained within 24 hours of admission to the intensive
care unit, we examined the association of right ventricular function with acute kidney injury (AKI) and AKI-
associated mortality. We also examined whether clinical measurement of volume overload modified the
association between ventricular function and AKI in a subpopulation with documented admission physical
examinations.
Methods: Among 1879 critically ill patients with echocardiographic ventricular measurements, 43%
(n ¼ 807) had ventricular dysfunction—21% (n ¼ 388), 9% (n ¼ 167), and 13% (n ¼ 252) with isolated left
ventricular dysfunction, isolated right ventricular dysfunction, and biventricular dysfunction, respectively.
Overall, ventricular dysfunction was associated with a 43% higher adjusted risk of AKI (95% confidence
interval [CI] 1.14–1.80; P ¼ 0.002) compared with those with normal biventricular function, whereas iso-
lated left ventricular dysfunction, isolated right ventricular dysfunction, and biventricular dysfunction were
associated with a 1.34 (95% CI 1.00-1.77, P ¼ 0.05), 1.35 (95% CI 0.90–2.10, P ¼ 0.14) and 1.67 (95% CI
1.23–2.31, P ¼ 0.002) higher adjusted risk. Although an episode of AKI was associated with an approxi-
mately 2-fold greater risk of hospital mortality in those with isolated left ventricular dysfunction and
biventricular dysfunction, in those with isolated right ventricular dysfunction, AKI was associated with a
7.85-fold greater risk of death (95% CI 2.89–21.3, P < 0.001). Independent of ventricular function, peripheral
edema was an important determinant of AKI.
Discussion: Like left ventricular function, right ventricular function is an important determinant of AKI and
AKI-associated mortality. Volume overload, independently of ventricular function, is a risk factor for AKI.
Whether establishment of euvolemia might mitigate AKI risk will require further study.
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enal dysfunction in the setting of heart failure,
termed the cardiorenal syndrome, has traditionally
been considered a hemodynamic consequence of left
ventricular dysfunction, whereby decreasing cardiac
output results in renal underperfusion and consequent
decreased glomerular filtration.1–3 However, emerging
data have highlighted the importance of the right
ventricle. Morphologically distinct, with thinner walls
less capable of pressure overload, the right ventricle
similarly regulates sodium homeostasis, and rightspondence: John Danziger, 172 Pilgrim Road – Libby 2,
n, MA 02215, USA. E-mail: jdanzige@bidmc.harvard.edu
ved 15 May 2017; accepted 28 May 2017; published online 9
2017
International Reports (2017) 2, 1059–1065ventricular dysfunction can lead to renin-angiotensin-
aldosterone activation, sodium retention, and volume
overload. Amidst the epidemiologic data linking
cardiac and renal pathophysiology, the importance of
the right ventricle has not been well described.
Furthermore, the role of volume overload, both a
consequence of heart failure and a potential mediator
of renal dysfunction, as a potential confounder in the
association between right ventricular function and
acute kidney injury (AKI) has not been fully
explored.4
Understanding the importance of the right ventricle
is hindered by a lack of established criteria to quantify
its function. Although a growing number of indexes
have been explored, these have not gained widespread
traction in clinical care. Nevertheless, standard clinical1059
CLINICAL RESEARCH C Chen et al.: Ventricular Dysfunction and Peripheral Edema Predict Acute Kidney Injurydescriptors of right and left ventricular function are
routinely documented in echocardiographic reports
and are used to inform clinical decision-making. Using
a large inception cohort of critically ill patients who
underwent routine echocardiography within the first
24 hours of intensive care unit (ICU) admission, we
examined the association of left, right, and biven-
tricular dysfunction with the risk of AKI as defined by
current guidelines, and we describe the risk of critical
illness mortality associated with an episode of AKI ac-
cording to ventricular function. In addition, in those
patients with documented physical examinations, we
explored the modifying effect of admission peripheral
edema on the risk of AKI.
METHODS
Study Population
We used the Medical Information Mart in Intensive
Care II database, a joint venture managed by the Lab-
oratory for Computational Physiology at Massachusetts
Institute of Technology and the Department of Medi-
cine at the Beth Israel Deaconess Medical Center. The
Medical Information Mart in Intensive Care II database
contains data from 23,455 unique critical care admis-
sions between 2001 and 2008 at Beth Israel Deaconess
Medical Center, a 700-bed urban academic medical
center with 77 adult ICU beds. The database contains
high temporal resolution data from clinical systems,
including laboratory results, provider electronic notes,
and bedside monitor trends and waveforms. Use of the
Medical Information Mart in Intensive Care II database
has been approved by the institutional review boards
of Beth Israel Deaconess Medical Center and the Mas-
sachusetts Institute of Technology. A total of 2451
patients had echocardiography performed within 24
hours of ICU admission. After 121 patients with end-
stage renal disease were excluded, 1953 had recorded
descriptions of both right and left ventricular function.
Of these, 32 patients were missing measures of renal
function, leaving a final sample size of 1879 in-
dividuals. In addition, we used a subsample of the
larger cohort with documented admission physical
examinations (n ¼ 1338) to study the effect of periph-
eral edema on AKI risk.
Primary Exposures
Ventricular function was determined by categoriza-
tion as a binary variable according to standard
clinical echocardiographic descriptors (Supplementary
Table S1). Ventricular function was primarily deter-
mined by description of regional systolic function, but
for those whose systolic function findings were absent,
ventricular function was determined by descriptive
terms of the ventricular cavity and wall. In those for1060whom descriptors of both regional systolic and cavity/
wall function were available, misclassification was
minimal. Five percent and 6% of individuals were
classified as having normal left and right regional
systolic function, respectively, but had abnormal
descriptors of regional wall cavity size. We classified
patients as having normal biventricular function,
isolated left ventricular dysfunction (iLVD), isolated
right ventricular function (iRVD), or biventricular
dysfunction (BiVD). The relatively small number of
patients with iRVD prevented further characterization
according to severity of ventricular dysfunction. In a
sensitivity analysis, we restricted our analysis to those
patients who had descriptions of both left and right
ventricular systolic function (n ¼ 1498) and examined
the association of isolated left ventricular systolic
dysfunction, isolated right ventricular systolic
dysfunction, and biventricular systolic dysfunction
with AKI and AKI-associated mortality. The reason for
obtaining the echocardiogram was not documented.Primary Outcomes
The primary outcome was AKI during the first 7 days
of ICU care, as defined by an increase of $ 0.3 mg/dl in
serum creatinine within 48 hours of ICU admission, an
increase of $ 50% within 7 days of ICU admission, or
acute dialysis, in keeping with the Kidney Disease
Improving Global Outcomes guidelines.5 Stage I AKI
was defined as an increase of 50% to 100%, Stage II as
an increase of > 100% to 200% increase, and Stage III
as an increase of > 200% or the immediate initiation of
dialysis. Following best practice guidelines, we used
the admission creatinine value to define “baseline.”6Covariates
Demographic information included age, sex, and race
(coded as white, African-American, Asian, Hispanic,
other, or unknown). We used treatment with oral
diabetes medication or insulin and International Clas-
sification of Diagnoses, 9th revision diagnostic coding
to identify patients with diabetes. The presence of
hypertension and liver disease was obtained from
Elixhauser discharge coding comorbidities.7,8 ICU
types included cardiac, surgical, cardiothoracic, and
medical. International Classification of Diagnoses, 9th
revision coding was used to identify admission for
acute myocardial infarction and pulmonary embolus,
and patients with sepsis were identified using previ-
ously defined methodology involving both Current
Procedural Terminology and International Classifica-
tion of Diagnoses, 9th revision codes.9 We included
hemoglobin and white blood cell count, defined as the
first available value 24 hours before or 6 hours afterKidney International Reports (2017) 2, 1059–1065
C Chen et al.: Ventricular Dysfunction and Peripheral Edema Predict Acute Kidney Injury CLINICAL RESEARCHICU admission. The time (in hours) from ICU admission
to echocardiogram testing was also included.
Statistical Analysis
We present baseline characteristics stratified by
ventricular function. Differences between continuous
and categorical variables were evaluated using t and
chi-squared tests, respectively, and P values for
differences across categories were provided. We used
logistic regression to examine the association between
admission ventricular function and the subsequent risk
of AKI, adjusting for the covariates described previ-
ously and including separate indicator variables for
iLVD, iRVD, and BiVD. Normal biventricular function
was considered the referent category.
We then describe the rate and risk of hospital
mortality in those with and without AKI, according to
ventricular function at the time of admission. We
explored separate multiplicative interaction terms
between AKI and iRVD, iLVD, and BiVD in the
adjusted analyses described previously and then pro-
vide the stratified adjusted risk, considering patients
who did not have AKI within each ventricular category
as reference.
In a sensitivity analysis, we explored alternative
definitions of the primary exposures, restricting to those
with right, left, and biventricular systolic dysfunction,
rather than the broader term that allowed description of
ventricular cavity function. We used the same statistical
approach described previously to examine the adjusted
association of isolated left ventricular systolic dysfunc-
tion, isolated right ventricular systolic dysfunction,








Age (yr) 66.8 (16.5) 65.3 (16.9) 69
Female (n, %) 877 (47.0) 545 (50.1) 17
ICU type
Cardiac 749 (39.9) 337 (31.4) 21
Medical 737 (39.2) 465 (43.4) 10
Surgical 253 (13.4) 169 (15.8) 48
Cardiothoracic 140 (7.4) 101 (9.42) 1
Admission diagnoses
Sepsis 318 (16.9) 196 (18.2) 55
Myocardial infarction 332 (17.6) 121 (11.3) 13
Pulmonary embolism 46 (2.4) 14 (1.3) 3
Admission characteristics
Diabetes (n, %) 639 (34.0) 345 (32.2) 15
Hypertension (n, %) 541 (28.7) 339 (31.6) 10
SOFA score (SD) 3.2 (2.3) 3.1 (2.3) 3
Creatinine (mg/dl) 1.6 (1.6) 1.5 (1.6) 1
Hemoglobin (g/dl) 11.6 (2.2) 11.4 (2.2) 11
Systolic blood pressure (mm Hg) 123.3 (27.7) 125.8 (29.1) 123
Values are expressed as mean with SDs in parentheses for continuous variables unless othe
ICU, intensive care unit; SOFA, sequential organ failure assessment.
Kidney International Reports (2017) 2, 1059–1065AKI-associated mortality. In addition, in those in-
dividuals with documented home medication lists
(n ¼ 1680), we included premorbid exposure to
diuretics, angiotensin-converting enzyme inhibitors,
and angiotensin receptor blockers as additional cova-
riates in the adjusted analyses described previously.
To explore the independent effects of volume over-
load and ventricular function on AKI risk, we used
Natural Language Processing of admission physical
examinations to describe the presence of peripheral
edema in those patients with documented admission
physical examinations (n ¼ 1338), as previously
described.10,11 We describe the incidence of AKI in
patients with and without peripheral edema on
admission according to ventricular function. We then
added a binary variable for peripheral edema to the
adjusted analysis, including measures of ventricular
function, explored multiplicative interaction terms
between peripheral edema and ventricular dysfunc-
tion, and provided the adjusted risk of developing AKI
for patients with peripheral edema, compared with
those without peripheral edema, according to ventric-
ular function.12RESULTS
Baseline Characteristics
Of the 1879 critically ill patients who underwent
echocardiography within 24 hours of ICU admission,
21% (n ¼ 388), 9% (n ¼ 167), and 13% (n ¼ 252) had
iLVD, iRVD, and BiVD, respectively (Table 1). As ex-
pected, pulmonary embolism was more common in





(n [ 252) P value
.7 (15.4) 66.5 (16.8) 68.8 (16.0) <0.001
1 (44.1) 74 (44.3) 87 (34.5) <0.001
2 (54.6) 54 (32.3) 146 (58.0) <0.001
9 (28.1) 88 (52.7) 75 (29.8)
(12.4) 18 (10.8) 18 (7.1)
9 (4.9) 7 (4.2) 13 (5.2)
(14.2) 25 (15.0) 42 (16.7) 0.26
8 (35.6) 19 (11.4) 54 (21.4) <0.001
(0.8) 26 (15.6) 3 (1.2) <0.001
0 (38.7) 48 (28.7) 96 (38.1) <0.001
3 (26.6) 48 (28.7) 51 (20.2) 0.002
.2 (2.2) 3.3 (2.4) 3.7 (2.4) <0.001
.6 (1.5) 1.5 (1.1) 1.9 (2.1) 0.02
.8 (2.1) 11.8 (2.1) 12.1 (2.3) <0.001
.1 (26.0) 119.7 (25.8) 115.7 (23.6) <0.001
rwise indicated.
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Table 2. Ventricular function and risk of acute kidney injury
Normal biventricular function















Values are expressed as odds ratios with 95% confidence intervals in parentheses) and
P values provided below. Adjustments were made for age, gender, race, intensive care
unit type, admission diagnosis (myocardial infarction, sepsis, pulmonary embolism, or
other), history of diabetes, hypertension or liver disease, white blood cell count, he-
moglobin, and hours from admission to echocardiogram. Reference category is patients
with normal biventricular function.
CLINICAL RESEARCH C Chen et al.: Ventricular Dysfunction and Peripheral Edema Predict Acute Kidney Injuryforms of ventricular dysfunction, whereas a diagnosis
of myocardial infarction was seen in almost 36% of
patients with iLVD. Blood pressure was lowest and
admission serum creatinine level was highest in those
with BiVD.
Risk of AKI
The overall incidence of AKI was 26% (n ¼ 485). Of the
patients with ventricular dysfunction, 29% (n ¼ 235)
developed AKI, compared with 23% (n ¼ 250) of pa-
tients with normal biventricular function. Of those
with iLVD, iRVD, and BiVD, 29% (n ¼ 112), 26%
(n ¼ 44), and 31% (n¼ 79) developed AKI, respectively
(Figure 1). Ventricular dysfunction was associated with
a significantly higher adjusted risk of AKI, particularly
among patients with BiVD (Table 2). When present,
AKI tended to be more severe with both iRVD and
BiVD (Figure 1). Stage III AKI occurred in 9% (n ¼ 15)
and 10% (n ¼ 26) of patients with iRVD and BiVD,
compared with 5% (n ¼ 20) and 7% (n ¼ 78) of pa-
tients with iLVD and normal biventricular function,
respectively.
In-Hospital Mortality
Of the patients with normal ventricular function, iLVD,
iRVD, and BiVD, 23% (n ¼ 241), 23% (n ¼ 84), 27%
(n ¼ 45), and 33% (n ¼ 84), respectively, died during
hospitalization for treatment of critical illness.
Although AKI was associated with higher hospital
mortality rates across all cardiac categories (Figure 2),
the association was strongest in those with iRVD
(multiplicative interaction between iRVD and AKI,
P ¼ 0.01). Although an episode of AKI was associated
with an approximately 2-fold greater risk of hospital
mortality in patients with iLVD and BiVD, in those
with iRVD, AKI was associated with a 7.85-fold greater
risk of death (95% confidence interval [CI] 2.89–21.3,

























Stage  I  AKI
Figure 1. Incidence and severity of acute kidney injury (AKI)
according to ventricular function.
1062AKI and AKI-associated Mortality in Those With
Ventricular Systolic Dysfunction
Of 1498 patients with a description of systolic function
available, 20% (n ¼ 295), 7% (n ¼ 104), and 15% (n ¼
225) had isolated left ventricular systolic dysfunction,
isolated right ventricular systolic dysfunction, and
biventricular systolic dysfunction, respectively. The
adjusted risks of AKI and AKI mortality are provided
in Table 4.
Home Medication Use
Of the patients with recorded home medication use,
38% (n ¼ 636), 27% (n ¼ 458), and 9% (n ¼ 146) were
prescribed diuretics, angiotensin-converting enzyme
inhibitors, and angiotensin receptor blockers, respec-
tively. Inclusion of these 3 classes of medication did not
meaningfully alter the findings described previously.
Peripheral Edema, Ventricular Function, and AKI
Among 1338 patients with documented admission
physical examinations, peripheral edema was observed
in 24% (n ¼ 188), 23% (n ¼ 64), 26% (n ¼ 29), and
30% (n ¼ 51) with normal biventricular function,
iLVD, iRVD, and BiVD, respectively. Peripheral edema
was associated with higher AKI incidence in patients
with all forms of ventricular dysfunction (Figure 3).























Acute kidney injury and mortality according to 
ventricular func on 
AKI
No AKI
Figure 2. Hospital mortality associated with an acute kidney injury
(AKI) episode according to ventricular function.
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Table 3. Risk of hospital mortality associated with acute kidney
injury according to ventricular function
Normal biventricular function

















Values are expressed as odds ratios with 95% confidence intervals in parentheses and
P values provided below. Adjustments were made for age, gender, race, intensive care
unit type, admission diagnosis (myocardial infarction, sepsis, pulmonary embolism, or
other), history of diabetes, hypertension or liver disease, white blood cell count, he-
moglobin, and hours from admission to echocardiogram. Reference category is patients


































Figure 3. Incidence of acute kidney injury (AKI) in patients with and
without peripheral edema according to ventricular function.
C Chen et al.: Ventricular Dysfunction and Peripheral Edema Predict Acute Kidney Injury CLINICAL RESEARCHfunction, admission peripheral edema was associated
with a 64% higher risk of AKI (95% CI 1.22–2.21,
P < 0.001). Peripheral edema did not significantly
modify the association between ventricular function
and AKI risk (multiplicative interaction term P values
all > 0.05), and even among those with normal
biventricular function (n ¼ 782), it was associated with
a higher adjusted risk of AKI (odds ratio 1.52, 95% CI
1.07–2.45, P ¼ 0.02). Among those with iLVD, iRVD,
and BiVD, the adjusted odds ratio of peripheral edema
with AKI was 0.85 (95% CI 0.42–01.74, P ¼ 0.67),
5.90 (95% CI 1.45–24.1, P ¼ 0.01), and 3.10 (95% CI
1.33–7.19, P ¼ 0.008), respectively.DISCUSSION
In critical illness, ventricular dysfunction is associated
with higher risks of AKI and AKI-associated mortality.
Although the risk of AKI is similar for patients with
iLVD and iRVD, the severity of AKI and the associated
risk of hospital mortality is highest among those with
iRVD. Furthermore, peripheral edema, a manifestation
of volume overload, is similarly associated with higher
AKI risk, an effect that is independent of ventricular























Values are expressed as odds ratios with 95% confidence intervals in parentheses and
P values provided below. Adjustments were made for age, gender, race, intensive care
unit type, admission diagnosis (myocardial infarction, sepsis, pulmonary embolism, or
other), history of diabetes, hypertension or liver disease, white blood cell count, he-
moglobin, and hours from admission to echocardiogram.
AKI, acute kidney injury.
aReference category is patients with normal biventricular function.
bReference category is patients without acute kidney injury within each ventricular
category.
Kidney International Reports (2017) 2, 1059–1065Our data add to the physiologic complexity under-
lying the cardiorenal syndrome, suggesting right
and left ventricular function might have different he-
modynamic consequences. Whereas the left ventricle
affects glomerular filtration through its changes in
contractility, cardiac output, and consequent renal
perfusion, the right ventricle seems to affect renal
function through different mechanisms, including
pulmonary hypertension, tricuspid regurgitation, and
a potential inhibitory effect on left ventricular func-
tion.13–17 Perhaps most important is venous congestion,
a manifestation of sodium avidity and fluid expansion,
as supported by emerging evidence. Directly
increasing renal venous pressure in animal models
causes sodium retention, lowers urinary output, and
decreases glomerular filtration18–21 and is widely
thought to explain AKI in the setting of the abdominal
compartment syndrome.22,23 In clinical studies, central
venous pressure is directly associated with renal
dysfunction, independently of ventricular func-
tion,13,24 and admission peripheral edema is associated
with higher mortality10 and greater risk of AKI.11 Such
awareness of a primary role of renal venous congestion
reshapes our understanding of renal function as not
simply a reflection of arterial perfusion, but rather a
balance between arterial supply and venous drainage.
In weighing the relative importance of right ven-
tricular function per se, or the consequent volume
overload that occurs as a result of ventricular
dysfunction, our data suggest a primary role for
both. In adjusted analysis, including measures of
ventricular function, peripheral edema remained
positively and independently associated with a
higher AKI risk, even among patients with normal
biventricular function.1063
CLINICAL RESEARCH C Chen et al.: Ventricular Dysfunction and Peripheral Edema Predict Acute Kidney InjuryUltimately, our data raise important clinical ques-
tions. If peripheral edema, independently of cardiac
function, is indeed associated with higher AKI risk,
then more aggressive diuretic and fluid management
strategies might improve outcomes. In multiple set-
tings, volume overload—as manifested by positive
fluid balance,12 peripheral edema,10 pulmonary edema,
bioimpedance, and central venous pressures—has been
associated with worse outcomes, and although the
mechanisms have not been clearly defined, worsening
renal function might be one explanation. Currently,
aggressive diuretic regimens to maintain euvolemia are
generally accepted in the care of patients with left-
sided heart failure. However, management of right
ventricular dysfunction lacks consensus. The idea of a
“preload”-dependent right ventricle requiring addi-
tional i.v. fluid primarily pertains to acute right
ventricular dilatation or infarction25 and has not been
studied in patients with chronic right ventricular
dysfunction. Fluid-restrictive strategies are now being
clinically tested, and a small trial showing a benefit of
fluid-restrictive strategies on renal function26 is now
being reproduced in a large, multicenter, randomized
controlled study.27
Our study has several important limitations.
Although we attempted to tease out the independent
roles of ventricular function and volume overload on
AKI risk, given the complex physiologic interdepen-
dence of volume status and cardiac function, such
distinctions are admittedly limited, particularly in
epidemiologic data. Furthermore, clinical measure-
ments of volume status are fraught with error. We
chose not to use central venous pressure measurements,
particularly because i.v. fluid administration is
frequently a clinical response to AKI. Instead, we used
physical examinations of volume status at the time of
admission, which are unlikely to be affected by care
provided in the study. Our observation that peripheral
edema was paradoxically associated with a lower risk
of AKI in patients with iLVD likely reflects a compo-
nent of selection bias, since volume overload is an
indication for ICU admission that is readily treatable
and is in keeping with the complex epidemiology be-
tween left ventricular function and outcome.28–30
Because our study was limited to critically ill
patients, the applicability of our findings to a broader
context is uncertain. The indication for performing
echocardiography was not known, potentially intro-
ducing selection bias into our analyses. We relied on
standard clinical echocardiographic descriptions of
ventricular function, which lack the sensitivity to
reliably characterize diastolic dysfunction and likely
introduce misclassification. Further studies with more
accurately adjudicated exposures are needed. Finally,1064we were unable to characterize baseline renal function
before critical illness.CONCLUSION
Both right and left ventricular function are important
determinants of AKI and AKI outcomes. Well-designed
studies to address whether stricter control of euvolemia
might mitigate this risk are warranted.DISCLOSURE
All the authors declared no competing interests.
ACKNOWLEDGMENTS
LAC’s work in the Laboratory for Computational Physi-
ology at the Massachusetts Institute of Technology is
funded by the National Institute of Biomedical Imaging and
Bioengineering under Grant R01-EB017205.
SUPPLEMENTARY MATERIAL
Table S1. Standard clinical descriptors used to determine
left and right ventricular function.
Supplementary material is linked to the online version of
the paper at www.kireports.org.
REFERENCES
1. Legrand M, Mebazaa A, Ronco C, Januzzi JL Jr. When cardiac
failure, kidney dysfunction, and kidney injury intersect in
acute conditions: the case of cardiorenal syndrome. Crit Care
Med. 2014;42:2109–2117.
2. Bongartz LG, Cramer MJ, Doevendans PA, et al. The severe
cardiorenal syndrome: ’Guyton revisited’. Eur Heart J.
2005;26:11–17.
3. Liang KV, Williams AW, Greene EL, et al. Acute decom-
pensated heart failure and the cardiorenal syndrome. Crit
Care Med. 2008;36(1 suppl):S75–S88.
4. Gnanaraj JF, von Haehling S, Anker SD, et al. The relevance
of congestion in the cardio-renal syndrome. Kidney Int.
2013;83:384–391.
5. Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commen-
tary on the 2012 KDIGO clinical practice guideline for acute
kidney injury. Am J Kidney Dis. 2013;61:649–672.
6. Ad-hoc Working Group of ERBP, Fliser D, Laville M, et al.
A European Renal Best Practice (ERBP) position statement on
the Kidney Disease Improving Global Outcomes (KDIGO)
clinical practice guidelines on acute kidney injury: part 1:
definitions, conservative management and contrast-induced
nephropathy. Nephrol Dial Transplant. 2012;27:4263–4272.
7. van Walraven C, Austin PC, Jennings A, et al. A modification
of the Elixhauser comorbidity measures into a point system
for hospital death using administrative data. Med Care.
2009;47:626–633.
8. Gutacker N, Bloor K, Cookson R. Comparing the performance
of the Charlson/Deyo and Elixhauser comorbidity measures
across five European countries and three conditions. Eur J
Public Health. 2015;25(suppl 1):15–20.Kidney International Reports (2017) 2, 1059–1065
C Chen et al.: Ventricular Dysfunction and Peripheral Edema Predict Acute Kidney Injury CLINICAL RESEARCH9. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of
sepsis in the United States from 1979 through 2000. N Engl J
Med. 2003;348:1546–1554.
10. Danziger J, Chen K, Cavender S, et al. Admission peripheral
edema, central venous pressure, and survival in critically ill
patients. Ann Am Thorac Soc. 2016;13:705–711.
11. Chen KP, Cavender S, Lee J, et al. Peripheral edema, central
venous pressure, and risk of AKI in critical illness. Clin J Am
Soc Nephrol. 2016;11:602–608.
12. Lee J, de Louw E, Niemi M, et al. Association between fluid
balance and survival in critically ill patients. J Intern Med.
2015;277:468–477.
13. Testani JM, Khera AV, St John Sutton MG, et al. Effect of right
ventricular function and venous congestion on cardiorenal
interactions during the treatment of decompensated heart
failure. Am J Cardiol. 2010;105:511–516.
14. Maeder MT, Holst DP, Kaye DM. Tricuspid regurgitation
contributes to renal dysfunction in patients with heart failure.
J Card Fail. 2008;14:824–830.
15. Little WC, Badke FR, O’Rourke RA. Effect of right ventricular
pressure on the end-diastolic left ventricular pressure-volume
relationship before and after chronic right ventricular pressure
overload in dogs without pericardia. Circ Res. 1984;54:719–730.
16. Haddad F, Fuh E, Peterson T, Skhiri M, Kudelko KT, De Jesus
Perez V, et al. Incidence, correlates, and consequences of
acute kidney injury in patients with pulmonary arterial hy-
pertension hospitalized with acute right-side heart failure.
J Card Fail. 2011;17(7):533–539.
17. Dini FL, Demmer RT, Simioniuc A, Morrone D, Donati F,
Guarini G, et al. Right ventricular dysfunction is associated
with chronic kidney disease and predicts survival in patients
with chronic systolic heart failure. Eur J Heart Fail. 2012;14(3):
287–294.
18. Blake WD, Wegria R, et al. Effect of increased renal venous
pressure on renal function. Am J Physiol. 1949;157(1):1–13.
19. Winton FR. The influence of venous pressure on the isolated
mammalian kidney. J Physiol. 1931;72(1):49–61.
20. Winton FR. The influence of increase of ureter pressure on the
isolated mammalian kidney. J Physiol. 1931;71(4):381–390.Kidney International Reports (2017) 2, 1059–106521. Doty JM, Saggi BH, Sugerman HJ, Blocher CR, Pin R,
Fakhry I, et al. Effect of increased renal venous pressure on
renal function. J Trauma. 1999;47(6):1000–1003.
22. Francis G. Acute decompensated heart failure: the car-
diorenal syndrome. Cleve Clin J Med. 2006;73 Suppl 2:
S8–S13. discussion S30–3.
23. Dalfino L, Tullo L, Donadio I, Malcangi V, Brienza N. Intra-
abdominal hypertension and acute renal failure in critically ill
patients. Intensive Care Med. 2008;34(4):707–713.
24. Mullens W, Abrahams Z, Francis GS, Sokos G,
Taylor DO, Starling RC, et al. Importance of venous
congestion for worsening of renal function in advanced
decompensated heart failure. J Am Coll Cardiol.
2009;53(7):589–596.
25. Mercat A, Diehl JL, Meyer G, Teboul JL, Sors H. Hemody-
namic effects of fluid loading in acute massive pulmonary
embolism. Crit Care Med. 1999;27(3):540–544.
26. Ternacle J, Gallet R, Mekontso-Dessap A, Meyer G, Maitre B,
Bensaid A, et al. Diuretics in normotensive patients with
acute pulmonary embolism and right ventricular dilatation.
Circ J. 2013;77(10):2612–2618.
27. Gallet R, Meyer G, Ternacle J, Biendel C, Brunet A,
Meneveau N, et al. Diuretic versus placebo in normotensive
acute pulmonary embolism with right ventricular enlarge-
ment and injury: a double-blind randomised placebo
controlled study. Protocol of the DiPER study. BMJ Open.
2015;5(5):e007466.
28. Parker MM, Shelhamer JH, Bacharach SL, Green MV,
Natanson C, Frederick TM, et al. Profound but reversible
myocardial depression in patients with septic shock. Ann
Intern Med. 1984;100(4):483–490.
29. Furian T, Aguiar C, Prado K, Ribeiro RV, Becker L,
Martinelli N, et al. Ventricular dysfunction and dilation
in severe sepsis and septic shock: relation to endothe-
lial function and mortality. J Crit Care. 2012;27(3)(319):
e9–e15.
30. Prabhu MM, Yalakala SK, Shetty R, Thakkar A,
Sitapara T. Prognosis of left ventricular systolic
dysfunction in septic shock patients. J Clin Diagn Res.
2015;9(3):OC05–OC08.1065
